GammaCore is a simple-to-use, handheld medical device that enables patients to self-administer discrete doses of non-invasive vagus nerve stimulation (nVNS) therapy to the neck.
Cluster headache is a series of extremely painful headaches that has been described by patients and physicians as one of the most painful conditions known to man, leading to the condition being referred to as the suicide headache. GammaCore is currently being utilised in the NHS as a safe, effective, and convenient treatment option for cluster headache.
In south London we are working with our three core neurology centres and have seen devices distributed to over 100 patients. Each device requires a new card every 93 days, a very simple process for patients .
Please get in touch at email@example.com for further information regarding the clinical, financial and patient benefits of GammaCore and for details regarding adopting the product in your organisation via the MTFM.
Benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is a term used to describe an enlarged prostate, a gland that surrounds the urethra. Excess prostate tissue can affect the flow of urine, making it difficult to empt
People living with sickle cell disease need frequent blood transfusion to manage their condition. Spectra Optia separates and removes sickle shaped red blood cells from patients’ blood and replaces
Thopaz+ portable digital system
Thopaz+ is a portable digital chest drain system, allowing patients who have had pulmonary resection, or a collapsed lung need a chest drain to stay mobile during their treatment, reducing drainage ti
When it comes to innovation, have you properly considered the role of community services? With changes to integrated care happening from July, community care is finally starting to get the recognition it deserves. We spoke to one of our partners, Dr Cath Jenson, Medical Director at Bromley Healthcare, about the difference they are making.
In 2018/19 King’s College Hospital NHS Foundation Trust was given a HIN Innovation Grant of £8,250 to set up a sexual health and wellbeing service, in partnership with cliniQ, a trans-led community interest company for trans, non-binary and gender diverse people, in south east London.